Related Experiment Videos
Suspected complication of treatment with venlafaxine
Journal of Clinical Psychopharmacology
|August 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
An overview of interventional pulmonary embolism management in the United Kingdom in 2026.
Clinical radiology·2026
Time to Splenic Embolisation in Trauma Patients Arriving at a Major Trauma Centre In-Hours or Out-of-Hours: A UK Multicentre Study.
Cardiovascular and interventional radiology·2026
Retrospective Observational Study of the Management of Blunt Traumatic Splenic Injury 2017-2022 at Major Trauma Centres in England. What is the Current Role of Splenic Artery Embolisation?
Cardiovascular and interventional radiology·2024
The Antidepressant Effects of the mGlu2/3 Receptor Antagonist TS-161 in Treatment-Resistant Depression: A Phase IIa Proof-of-Concept Clinical Trial.
Journal of clinical psychopharmacology·2026
The Randomization Effect in a Double-Blind Placebo-Controlled Depression Study.
Journal of clinical psychopharmacology·2026
Memantine Augmentation for Obsessive-Compulsive Symptoms in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
Journal of clinical psychopharmacology·2026
Partial Dopamine Agonists and Gambling Disorder: A Comprehensive Review and Clinical Implications.
Journal of clinical psychopharmacology·2026
Unintentional Lithium Toxicity in Patients With Bipolar Disorder: A Literature Review of Case Reports.
Journal of clinical psychopharmacology·2026
Development of a rapid colorimetric method for detection of synthetic corticosteroids in food and dietary supplements.
Analytical methods : advancing methods and applications·2026
Predominant α₂-adrenoceptor control of chelonian systemic resistance arteries provides a mechanistic basis for the cardiovascular effects of α₂-agonist sedation.
American journal of physiology. Heart and circulatory physiology·2026
Management of erectile dysfunction in phosphodiesterase type 5 inhibitor nonresponders.
Current opinion in urology·2026